Ute Berger
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 29
- Acute Myeloid Leukemia Research 5
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 16
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 4
-
- Neutropenia and Cancer Infections 2
-
- Adenosine and Purinergic Signaling 1
- Co-authors
- Andreas HochhausRüdiger HehlmannClaudia SchochNicholas C.P. CrossTanja LahayeSebastian KreilAndreas ReiterPaul La Rosée
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Ute Berger
31 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Hematology 1.7k
- Genetics 1.4k
- Rheumatology 936
- Pathology and Forensic Medicine 189
- Public Health, Environmental and Occupational Health 263
Countries citing papers authored by Ute Berger
This map shows the geographic impact of Ute Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Berger more than expected).
Fields of papers citing papers by Ute Berger
This network shows the impact of papers produced by Ute Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Berger. The network helps show where Ute Berger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ute Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 162 | |
| 2 | 2006 | 6 | |
| 3 | 2005 | 54 | |
| 4 | 2005 | 41 | |
| 5 | 2005 | 191 | |
| 6 | 2004 | 23 | |
| 7 | 2004 | 1 | |
| 8 | 2003 | 13 | |
| 9 | 2003 | 23 | |
| 10 | 2003 | 65 | |
| 11 | Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapybreakdown → | 2002 | 675 |
| 12 | Molecular and chromosomal mechanisms of resistance in CML patients after STI571 (Glivec) therapy | 2001 | 16 |
| 13 | 2001 | 4 | |
| 14 | 2000 | 74 | |
| 15 | 2000 | 63 | |
| 16 | 2000 | 3 | |
| 17 | 2000 | 31 | |
| 18 | 1999 | 207 | |
| 19 | Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group. | 1997 | 3 |
| 20 | 1996 | 96 |
About Ute Berger
Ute Berger is a scholar working on Hematology, Genetics, Rheumatology, Developmental Neuroscience and History and Philosophy of Science, having authored 33 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (29 papers), Chronic Lymphocytic Leukemia Research (17 papers), Eosinophilic Disorders and Syndromes (16 papers), Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Neutropenia and Cancer Infections (2 papers) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Hematology (1.7k citations), Genetics (1.4k citations), Rheumatology (936 citations), Pathology and Forensic Medicine (189 citations) and Public Health, Environmental and Occupational Health (263 citations). Ute Berger has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Andreas Hochhaus, Rüdiger Hehlmann, Claudia Schoch, Nicholas C.P. Cross, Tanja Lahaye, Sebastian Kreil, Andreas Reiter, Paul La Rosée, Harald Gschaidmeier and A. Corbin. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.